OOIR: Observatory of International Research

Papers

(The TQCC of Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Recent advances in development of dendritic polymer‐based nanomedicines for cancer diagnosis	131
Multifunctional MnO₂ nanoparticles for tumor microenvironment modulation and cancer therapy	97
Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseases	86
Nanoparticle contrast agents for X‐ray imaging applications	69
Strategies for sustained drug release from electrospun multi‐layer nanostructures	68
Nanobody—A versatile tool for cancer diagnosis and therapeutics	66
Nanomedicine and drug delivery systems in cancer and regenerative medicine	62
Ultrasmall superparamagnetic iron oxide nanoparticles: A next generation contrast agent for magnetic resonance imaging	58
Intrinsic stimuli‐responsive nanocarriers for smart drug delivery of antibacterial agents—An in‐depth review of the last two decades	53
Silver nanoparticles as a potential treatment against SARS‐CoV‐2: A review	45
Mechanisms of nanoparticle radiosensitization	41
Influence of surface chemistry and morphology of nanoparticles on protein corona formation	40
Nanocarrier‐hydrogel composite delivery systems for precision drug release	40
Reduction‐responsive polymers for drug delivery in cancer therapy—Is there anything new to discover?	39
Surface modification of nano‐drug delivery systems for enhancing antibiotic delivery and activity	39
Recent advances in applications of nanoparticles in SERS in vivo imaging	38
Understanding the mechanisms of silica nanoparticles for nanomedicine	37
Rational design of nanomedicine for photothermal‐chemodynamic bimodal cancer therapy	36
Gold nanoparticles in virus detection: Recent advances and potential considerations for SARS‐CoV‐2 testing development	36
Advances in engineering local drug delivery systems for cancer immunotherapy	35
Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy	35
Electrospun fibers as carriers for topical drug delivery and release in skin bandages and patches for atopic dermatitis treatment	33
Clinical magnetic hyperthermia requires integrated magnetic particle imaging	32
T‐cell targeted pulmonary siRNA delivery for the treatment of asthma	32
Stimuli‐responsive nanoplatforms for antibacterial applications	30

Advancements in protein nanoparticle vaccine platforms to combat infectious disease	29
Advances of nanomaterial applications in oral and maxillofacial tissue regeneration and disease treatment	29
Synthetic cells in biomedical applications	29
Advances and perspectives in near‐infrared fluorescent organic probes for surgical oncology	28
Nucleic acid‐based electrochemical biosensor: Recent advances in probe immobilization and signal amplification strategies	28
Advancements in release‐active antimicrobial biomaterials: A journey from release to relief	28
Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors	27
Nanomaterials with active targeting as advanced antimicrobials	27
Recent advances in combination of microneedles and nanomedicines for lymphatic targeted drug delivery	27
Two‐dimensional metal organic frameworks for biomedical applications	26
Applications of nanotechnology in virus detection, tracking, and infection mechanisms	25
Copper‐based nanomaterials for cancer theranostics	25
Catalytic antimicrobial therapy using nanozymes	25
Recent developments in the use of gold and silver nanoparticles in biomedicine	24
Nanobiotechnology‐enabled energy utilization elevation for augmenting minimally‐invasive and noninvasive oncology thermal ablation	24
Image‐guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies	23
Red blood cells membrane‐derived nanoparticles: Applications and key challenges in their clinical translation	22
Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery	22
Hot spot ¹⁹F magnetic resonance imaging of inflammation	22
Recent advances on synthesis and biomaterials applications of hyperbranched polymers	22
Biohybrid robotics: From the nanoscale to the macroscale	22
Challenges in the development of nanoparticle‐based imaging agents: Characterization and biology	21
Direct treatment versus indirect: Thermo‐ablative and mild hyperthermia effects	21
Recent progress in layered double hydroxides as a cancer theranostic nanoplatform	21
Chiral fiber supramolecular hydrogels for tissue engineering	20
Plant viral nanoparticles for packaging and in vivo delivery of bioactive cargos	20
Biogenic nanoparticles as immunomodulator for tumor treatment	20
In vitro dissolution considerations associated with nano drug delivery systems	19
Cell membrane‐coated nanoparticles for the treatment of bacterial infection	19
Dark‐field hyperspectral imaging for label free detection of nano‐bio‐materials	19
Advances in single‐molecule fluorescent nanosensors	19
Going even smaller: Engineering sub‐5 nm nanoparticles for improved delivery, biocompatibility, and functionality	18
Exploring the applications of hyaluronic acid‐based nanoparticles for diagnosis and treatment of bacterial infections	18
Cancer‐associated‐platelet‐inspired nanomedicines for cancer therapy	18
Hot melt extrusion: An emerging manufacturing method for slow and sustained protein delivery	18
Engineering gold nanoparticles for molecular diagnostics and biosensing	18
Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy	18
Cell mimicry as a bottom‐up strategy for hierarchical engineering ofnature‐inspiredentities	18
Therapeutic gas delivery strategies	18
Recent advances on transdermal delivery systems for the treatment of arthritic injuries: From classical treatment to nanomedicines	17
Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy	17
Nanomedicines for combating multidrug resistance of cancer	17
NIR light‐triggered nanomaterials‐based prodrug activation towards cancer therapy	17
Management of osteoarthritis: From drug molecules to nano/micromedicines	17
Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies	17
Crosslinked polymer nanocapsules for therapeutic, diagnostic, and theranostic applications	17
Combinational application of metal–organic frameworks‐based nanozyme and nucleic acid delivery in cancer therapy	17
Engineering spatiotemporal organization and dynamics in synthetic cells	16
Nanoparticle mediated RNA delivery for wound healing	16
Remodeling tumor microenvironment with nanomedicines	16

Optimal delivery of poorly soluble drugs using electrospun nanofiber technology: Challenges, state of the art, and future directions	16
Titanium dioxide nanoparticles: Recent progress in antimicrobial applications	16
Direct nose to the brain nanomedicine delivery presents a formidable challenge	16
A review on RNAi therapy for NSCLC: Opportunities and challenges	16
From infection to healing: The use of plant viruses in bioactive hydrogels	15
Targeting cancer metastasis with antibody therapeutics	15
Inflammation‐modulating nanoparticles for pneumonia therapy	15
Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics	15
Graphene nanocomposites for transdermal biosensing	15
Nano‐diagnostics as an emerging platform for oral cancer detection: Current and emerging trends	14
Toward nanobioelectronic medicine: Unlocking new applications using nanotechnology	14
Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma	14